In 2016-2020 period Russia's market for musculoskeletal drugs is expected to grow twice faster than the market for the same in the UK.
(1888PressRelease) October 21, 2017 - Between 2016 and 2020 the Russian market for the drugs that treat diseases such as arthritis, osteoporosis, osteomalacia, carpal tunnel syndrome and muscular dystrophy will grow at twice the speed of the next fastest European country, the UK, at nearly 15% against 7% year on year. This will bring the worth of the Russian market in 2020 up to a figure twice that of Spain's, where the market is growing very slowly and within catching distance of France's by 2022.
Many musculoskeletal disorders are incurable so that patients will take these pain- and inflammation-reducing drugs either continuously or periodically for life. As their incidence is age-related, the increase in the size of the aging population is one factor driving the growth of this market. Other factors are increasing global obesity and stress levels.
Globally, the market for musculosketal drugs equates to about 14% of the pharma total and is growing at over 7% year on year. This compares with growth rates around 5% for pharmaceuticals in general.
The benefits of growth in these markets will be widely distributed. Although the leading manufacturers of these drugs are the Swiss company Hoffmann-La Roche, the British GlaxoSmithKline and the USA’s Pfizer, the top ten pharma companies together only account for around 10% of global sales. Small pharma companies in the emerging economies and generic drugs account for the majority of sales of these products.
Where to Learn More
Read Musculoskeletal Disorders Drugs Market Global Report 2017 from The Business Research Company for information on the following:
Markets Covered: Rheumatoid Arthritis, Muscle Relaxants, Others
Companies Mentioned: AbbVie, Amgen, Johnson & Johnson, F. Hoffmann-La Roche Ltd, and Pfizer Inc.
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Musculoskeletal Disorders Drugs Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Interested to know more? Here is a full scope of Biologics and Pharmaceutical Drugs
Market reports to explore:
1. Pharmaceutical Drugs Market Global Report 2017
2. Anti-infective Drugs Market Global Report 2017
3. Cardiovascular Drugs Market Global Report 2017
4. Central Nervous System Drugs Market Global Report 2017
5. Dermatology Drugs Market Global Report 2017
6. Genito-urinary Drugs Market Global Report 2017
7. Hematology Drugs Market Global Report 2017
8. Metabolic Disorder Drugs Market Global Report 2017
9. Ophthalmology Drugs Market Global Report 2017
10. Gastrointestinal Drugs Market Global Report 2017
11. Respiratory Drugs Market Global Report 2017
12. Biologics Market Global Report 2017
13. Oncology Drugs Market Global Report 2017
About The Business Research Company
Visit TheBusinesResearchCompany.com. The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has research professionals at its office in the UK, India, and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. The Business Research Company’s management have more than 20 years of varied business research experience. They have delivered hundreds of research projects to the senior management of some of the world’s largest organizations. The Business Research Company’s Consultant have master’s qualifications from top institutes and include MBAs, MSCs, CFAs and CAs. The Business Research Company’s Consultants gain training and qualifications from the market Research Society and are trained in advanced research practices, techniques, and ethics.
In 2016-2020 period Russia's market for musculoskeletal drugs is expected to grow twice faster than the market for the same in the UK. 
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam